Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
390
-
Total 13F shares, excl. options
-
157,700,975
-
Shares change
-
+926,693
-
Total reported value, excl. options
-
$21,572,249,632
-
Value change
-
+$147,538,663
-
Put/Call ratio
-
1.02%
-
Number of buys
-
209
-
Number of sells
-
-164
-
Price
-
$136.78
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2015
467 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q2 2015.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 390 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 157,700,975 shares
of 193,539,047 outstanding shares and own 81.48% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (19,637,821 shares), FMR LLC (13,858,562 shares), SANDS CAPITAL MANAGEMENT, LLC (11,627,607 shares), VANGUARD GROUP INC (10,593,016 shares), PRICE T ROWE ASSOCIATES INC /MD/ (7,997,463 shares), PRIMECAP MANAGEMENT CO/CA/ (7,992,749 shares), JENNISON ASSOCIATES LLC (5,498,822 shares), BAKER BROS. ADVISORS LP (4,095,247 shares), BlackRock Institutional Trust Company, N.A. (3,769,564 shares), and BlackRock Fund Advisors (3,587,294 shares).
This table shows the top 390 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.